v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Private Placement
Public Offering
Public Placement
Common Stock
Common Stock
Private Placement
Common Stock
Public Offering
Additional Paid-in Capital
Additional Paid-in Capital
Private Placement
Additional Paid-in Capital
Public Offering
Additional Paid-in Capital
Public Placement
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024 [1]         8,931              
Beginning balance at Dec. 31, 2024 [1] $ (9,538)       $ 1     $ 22,402       $ (31,941)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of shares of common stock (in shares) [1]         330              
Issuance of shares of common stock [1] 299             299        
Issuance of warrants 381             381        
Exercise of pre-funded warrants and Conversion of long-term debt into shares of common stock (in shares) [1]         295              
Exercise of pre-funded warrants and Conversion of long-term debt into shares of common stock [1] 366             366        
Reclassification of warrant liability upon warranty modification 22,986             22,986        
Stock-based compensation 320             320        
Net loss (15,138)                     (15,138)
Ending balance (in shares) at Jun. 30, 2025 [1]         9,556              
Ending balance at Jun. 30, 2025 [1] (324)       $ 1     46,754       (47,079)
Beginning balance (in shares) at Mar. 31, 2025 [1]         9,226              
Beginning balance at Mar. 31, 2025 [1] (20,207)       $ 1     22,869       (43,077)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of shares of common stock (in shares) [1]         330              
Issuance of shares of common stock [1] 299             299        
Issuance of warrants 381             381        
Reclassification of warrant liability upon warranty modification 22,986             22,986        
Stock-based compensation 219             219        
Net loss (4,002)                     (4,002)
Ending balance (in shares) at Jun. 30, 2025 [1]         9,556              
Ending balance at Jun. 30, 2025 [1] $ (324)       $ 1     46,754       (47,079)
Beginning balance (in shares) at Dec. 31, 2025 11,902       11,902              
Beginning balance at Dec. 31, 2025 $ 6,445       $ 1     59,468       (53,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of shares of common stock (in shares)           24 1,200          
Issuance of shares of common stock   $ 39 $ 5,347           $ 39 $ 5,347    
Issuance of warrants   $ 95   $ 3,564         $ 95   $ 3,564  
Exercise of pre-funded warrants and Conversion of long-term debt into shares of common stock (in shares)         500              
Equity award activity, net of shares withheld for taxes (in shares)         143              
Equity award activity, net of shares withheld for taxes 183             183        
Stock-based compensation 1,049             1,049        
Net loss $ (14,476)                     (14,476)
Ending balance (in shares) at Jun. 30, 2026 13,769       13,769              
Ending balance at Jun. 30, 2026 $ 2,246       $ 1     69,745       (67,500)
Beginning balance (in shares) at Mar. 31, 2026         12,042              
Beginning balance at Mar. 31, 2026 3,799       $ 1     60,228       (56,430)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of shares of common stock (in shares)         1,200              
Issuance of shares of common stock 5,347             5,347        
Issuance of warrants 3,564             3,564        
Exercise of pre-funded warrants and Conversion of long-term debt into shares of common stock (in shares)         500              
Equity award activity, net of shares withheld for taxes (in shares)         27              
Equity award activity, net of shares withheld for taxes (62)             (62)        
Stock-based compensation 668             668        
Net loss $ (11,070)                     (11,070)
Ending balance (in shares) at Jun. 30, 2026 13,769       13,769              
Ending balance at Jun. 30, 2026 $ 2,246       $ 1     $ 69,745       $ (67,500)
[1] Amounts and share amounts as of June 30, 2025 and prior to that date differ from those published in prior unaudited condensed consolidated financial statements as they were retrospectively adjusted as a result of the Reverse Stock Split (refer to Note 1 - The Company and Summary of Significant Accounting Policies). Specifically, the number of common shares outstanding during the periods before the Reverse Stock Split are divided by the exchange ratio of 3:1, such that each three shares of common stock were combined and reconstituted into one share of common stock effective October 23, 2025.